Get the Stockscreener App
7.805
5.74%
-0.515
Treace Medical Concepts Inc Stock (TMCI) Forecast
The Treace Medical Concepts Inc (TMCI) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $4.5581, representing a -41.60% decrease from the current price of $7.805. The highest analyst price target is $5.9827, and the lowest is $3.1336.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month TMCI Price Target
Average 11.13
(+42.56% Upside)
Is Treace Medical Concepts Inc (TMCI) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 38.60 | Neutral |
| STOCH(9,6) | 41.01 | Neutral |
| STOCHRSI(14) | 33.88 | Neutral |
| MACD(12,26) | -0.2016 | Buy |
| ADX(14) | 13.40 | Neutral |
| William %R | -77.50 | Neutral |
| CCI(14) | -133.03 | Sell |
Buy: 1
Sell: 1
Neutral: 5
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
8.364
Sell
|
8.2843
Sell
|
| MA20 |
8.2815
Sell
|
8.4297
Sell
|
| MA50 |
9.1415
Sell
|
8.6044
Sell
|
| MA100 |
8.4962
Sell
|
8.3216
Sell
|
| MA200 |
7.2906
Buy
|
8.4293
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, TMCI could be considered a Strong Sell, with 17 technical analysis indicators signaling 2 Buy signals, 10 signaling Sell signals and 5 Neutral signals. This might not be a good time to consider opening new positions on TMCI, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 38.6 indicates that TMCI is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 41.01 indicates that TMCI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 33.88 indicates that TMCI is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 13.4 indicates that there is no clear directional movement, and the market may be ranging or moving sideways.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -133.03 indicates that TMCI is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term TMCI price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Treace Medical Concepts Inc financial reports and earnings history, Treace Medical Concepts Inc (TMCI) stock could reach $5.8593 by 2030, $54.03 by 2040 and $90.21 by 2050. See the projected annual prices until 2050 of the Treace Medical Concepts Inc stock below:
- Treace Medical Concepts Inc (TMCI) is expected to reach an average price of $18.96 in 2035, with a high prediction of $20.90 and a low estimate of $19.35. This indicates an $142.92% rise from the last recorded price of $7.805.
- Treace Medical Concepts Inc (TMCI) stock is projected to chart a bullish course in 2040, with an average price target of $55.59, representing an $612.24% surge from its current level. The forecast ranges from a conservative $19.72 to a sky-high $54.03.
- Our analysts predict Treace Medical Concepts Inc (TMCI) to jump 386.86% by 2045, soaring from $39.63 to an average price of $38.00, potentially reaching $42.08. While $39.63 is the low estimate, the potential upside is significant.
- Treace Medical Concepts Inc (TMCI) stock is expected to climb by 2050, reaching an average of $87.25, a $1,018% jump from its current level. However, a wide range of estimates exists, with high and low targets of $90.21 and $89.62, respectively, highlighting the market's uncertainty.
Treace Medical Concepts Inc Stock (TMCI) Year by Year Forecast
Treace Medical Concepts Inc Stock (TMCI) Price Forecast for 2025
Treace Medical Concepts Inc Stock (TMCI) is expected to reach an average price of $9.121 in 2025, with a high prediction of $17.05 and a low estimate of $1.1968. This indicates an +16.86% rise from the last recorded price of $7.805.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| May, 2025 | $5.9127 | $3.1336 | $5.9827 | -24.24% |
| June, 2025 | $8.9111 | $4.4665 | $9.2411 | +14.17% |
| July, 2025 | $9.2341 | $7.6749 | $11.32 | +18.31% |
| August, 2025 | $11.81 | $9.0987 | $14.65 | +51.35% |
| September, 2025 | $13.95 | $10.98 | $14.44 | +78.74% |
| October, 2025 | $12.35 | $9.4393 | $15.09 | +58.28% |
| November, 2025 | $13.27 | $11.77 | $15.32 | +70.05% |
| December, 2025 | $16.49 | $12.54 | $17.05 | +111.21% |
Treace Medical Concepts Inc Stock (TMCI) Price Forecast for 2026
The predicted value for Treace Medical Concepts Inc (TMCI) in 2026 is set at an average of $10.02. Estimates vary from a peak of $19.14 to a trough of $0.895, indicating an +28.33% surge from the present price of $7.805.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $11.74 | $11.42 | $17.03 | +50.46% |
| February, 2026 | $11.90 | $11.12 | $13.45 | +52.49% |
| March, 2026 | $16.27 | $10.50 | $17.18 | +108.46% |
| April, 2026 | $17.77 | $15.67 | $19.12 | +127.72% |
| May, 2026 | $18.08 | $11.92 | $19.14 | +131.67% |
| June, 2026 | $17.21 | $16.31 | $18.94 | +120.50% |
| July, 2026 | $15.14 | $13.86 | $17.46 | +94.02% |
| August, 2026 | $8.7814 | $8.2268 | $15.21 | +12.51% |
| September, 2026 | $6.6644 | $5.7118 | $8.776 | -14.61% |
| October, 2026 | $2.5728 | $2.0228 | $7.359 | -67.04% |
| November, 2026 | $3.6812 | $1.777 | $3.9712 | -52.84% |
| December, 2026 | $2.1741 | $0.895 | $4.1658 | -72.14% |
Treace Medical Concepts Inc Stock (TMCI) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Treace Medical Concepts Inc (TMCI) is $4.7564, with a high forecast of $9.3793 and a low forecast of $0.1335. This indicates an -39.06% decrease from the last price of $7.805.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $5.7925 | $1.7287 | $6.0725 | -25.78% |
| February, 2027 | $6.0409 | $4.1771 | $7.5117 | -22.60% |
| March, 2027 | $7.6939 | $5.9305 | $9.3793 | -1.42% |
| April, 2027 | $5.5023 | $5.2923 | $8.3035 | -29.50% |
| May, 2027 | $5.6807 | $5.1515 | $6.9961 | -27.22% |
| June, 2027 | $2.43 | $2.56 | $5.7952 | -68.87% |
| July, 2027 | $0.9968 | $0.9832 | $2.1868 | -87.23% |
| August, 2027 | $1.0335 | $0.1335 | $5.0643 | -86.76% |
| September, 2027 | $2.4005 | $0.1627 | $1.7505 | -69.24% |
| October, 2027 | $7.1738 | $2.5413 | $5.4238 | -8.09% |
| November, 2027 | $8.167 | $7.8954 | $6.7746 | +4.64% |
| December, 2027 | $5.751 | $5.901 | $7.3078 | -26.32% |
Treace Medical Concepts Inc Stock (TMCI) Price Forecast for 2028
In 2028, Treace Medical Concepts Inc (TMCI) is projected to reach an average price of $3.6278, with a high projection of $7.1363 and a low estimate of $0.1193. This indicates an -53.52% fall from the last price of $7.805.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $3.5843 | $5.9543 | $5.9227 | -54.08% |
| February, 2028 | $3.0675 | $2.9267 | $2.3059 | -60.70% |
| March, 2028 | $3.6016 | $4.2216 | $3.3416 | -53.86% |
| April, 2028 | $3.1448 | $3.8348 | $2.7348 | -59.71% |
| May, 2028 | $5.6089 | $5.8089 | $6.5872 | -28.14% |
| June, 2028 | $6.6821 | $6.1097 | $7.1363 | -14.39% |
| July, 2028 | $5.3153 | $6.1853 | $6.9837 | -31.90% |
| August, 2028 | $1.4894 | $2.8193 | $4.9461 | -80.92% |
| September, 2028 | $2.7474 | $1.2926 | $3.3974 | -64.80% |
| October, 2028 | $2.2341 | $0.616 | $4.3066 | -71.38% |
| November, 2028 | $2.0601 | $0.8133 | $5.0401 | -73.61% |
| December, 2028 | $3.5269 | $0.1193 | $5.1885 | -54.81% |
Treace Medical Concepts Inc Stock (TMCI) Price Forecast for 2029
The 2029 price forecast for Treace Medical Concepts Inc Stock (TMCI) is $5.4089 on average, with a high prediction of $10.57 and a low estimate of $0.2437. This represents an -30.70% decrease from the previous price of $7.805.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $3.8128 | $3.1094 | $5.6444 | -51.15% |
| February, 2029 | $6.5696 | $2.992 | $7.6196 | -15.83% |
| March, 2029 | $3.6163 | $2.1472 | $6.5788 | -53.67% |
| April, 2029 | $5.9631 | $1.4431 | $7.8931 | -23.60% |
| May, 2029 | $7.0791 | $4.6323 | $10.29 | -9.30% |
| June, 2029 | $7.8558 | $3.2658 | $9.5982 | +0.65% |
| July, 2029 | $9.8326 | $7.715 | $10.57 | +25.98% |
| August, 2029 | $6.7485 | $6.3485 | $9.791 | -13.54% |
| September, 2029 | $6.6453 | $5.7461 | $8.8319 | -14.86% |
| October, 2029 | $0.1487 | $0.2437 | $6.5645 | -98.09% |
| November, 2029 | $1.962 | $0.3246 | $0.4288 | -74.86% |
| December, 2029 | $5.0752 | $3.4028 | $4.3452 | -34.97% |
Treace Medical Concepts Inc Stock (TMCI) Price Forecast for 2030
Treace Medical Concepts Inc Stock (TMCI) is expected to reach an average price of $9.676 in 2030, with a high forecast of $19.26 and a low forecast of $0.0902. This signifies an +23.97% surge from the last price of $7.805.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $6.0993 | $5.0777 | $5.8593 | -21.85% |
| February, 2030 | $4.6825 | $5.3625 | $5.0901 | -40.01% |
| March, 2030 | $1.9357 | $1.7649 | $3.0433 | -75.20% |
| April, 2030 | $0.011 | $0.804 | $0.6974 | -99.86% |
| May, 2030 | $0.417 | $0.0902 | $2.7786 | -94.66% |
| June, 2030 | $0.5063 | $0.1553 | $0.9553 | -93.51% |
| July, 2030 | $1.8203 | $0.6387 | $0.8303 | -76.68% |
| August, 2030 | $15.23 | $1.6619 | $14.16 | +95.08% |
| September, 2030 | $11.87 | $12.34 | $13.78 | +52.10% |
| October, 2030 | $13.10 | $11.78 | $11.76 | +67.87% |
| November, 2030 | $14.16 | $15.21 | $14.46 | +81.38% |
| December, 2030 | $20.15 | $16.75 | $19.26 | +158.19% |
2.07%
0.89%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):